RPG Life Sciences Ltd.
Snapshot View

827.95 +4.55 ▲0.6%

07 February 2023, 09:57:55 AM
Volume: 4,390

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.rpglifesciences.com
Market Cap 1,363.72 Cr.
Enterprise Value(EV) 1,299.86 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 39.19 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 21.04 Trailing Twelve Months Ending 2022-12
Industry PE 32.80 Trailing Twelve Months Ending 2022-12
Book Value / Share 179.61 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.59 Calculated using Price: 824.55
Dividend Yield 1.16 Period Ending 2022-03
No. of Shares Subscribed 1.65 Cr. 16,539,015 Shares
FaceValue 8
Company Profile
RPG Life Sciences (RPGLS) is a pharmaceutical organization and was formerly known as Searle (India) Limited. It is a full spectrum world class, customer focussed, innovative pharmaceutical organisation. RPGLS started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to the RPG Group. The company's name was changed to RPG Life Sciences Ltd effective April 1, 1999.This company belongs to RPG group

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.55%
1 Week
+4.45%
1 Month
+0.42%
3 Month
-5.31%
6 Month
+28.48%
1 Year
+43.06%
2 Year
+100.86%
5 Year
+90.38%
10 Year
+1126.59%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 52.87 0.80 8.98 14.98 8.91 6.86 17.21 20.36 21.80
Return on Capital Employed (%) 48.37 2.50 8.97 15.58 12.52 9.81 20.35 27.27 31.46
Return on Assets (%) 25.50 0.47 5.34 9.15 5.17 4.07 11.25 14.00 15.89

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 126 125 134 147 155 161 177 216 256 278
Non Curr. Liab. 7 20 22 11 8 10 9 7 9 8
Curr. Liab. 77 67 67 79 121 78 83 80 80 88
Minority Int.
Equity & Liab. 209 212 223 236 284 248 268 303 345 374
Non Curr. Assets 112 126 136 140 141 151 142 127 138 139
Curr. Assets 97 86 87 96 143 97 126 176 207 235
Misc. Exp. not W/O
Total Assets 209 212 223 236 284 248 268 303 345 374

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 236 242 279 294 344 330 376 389 440 498
Other Income 3 7 2 10 2 1 1 1 3 4
Total Income 238 249 281 303 346 331 377 390 443 502
Total Expenditure -224 -234 -257 -265 -307 -296 -316 -318 -353 -398
PBIDT 14 15 24 38 39 35 61 72 90 105
Interest -3 -3 -2 -4 -5 -5 -3 -2 -1 0
Depreciation -11 -11 -10 -11 -14 -15 -16 -16 -16 -15
Taxation -12 -2 -7 -4 -7 -14 -22 -24
Exceptional Items 64 -5
PAT 53 1 12 21 13 11 29 40 51 65
Adjusted EPS 32 1 7 13 8 7 18 24 31 39

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 12 -6 -2 33 7 15 46 50 58 65
Cash Fr. Inv. -12 59 -10 -15 -30 -16 -19 -11 -8 -35
Cash Fr. Finan. 0 -54 12 -18 23 0 -27 -39 -10 -14
Net Change 0 0 0 1 -1 0 0 40 17
Cash & Cash Eqvt 0 0 0 0 1 0 0 1 40 57

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 72.07 72.07 72.07 72.07 72.07 72.07 72.41 72.61 72.61
Public 27.93 27.93 27.93 27.93 27.93 27.93 27.59 27.39 27.39
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 03 Feb 2023
Investor Presentation
RPG Life Sciences Limited has informed the Exchange about Investor Presentation
Fri, 03 Feb 2023
Financial Result Updates
RPG Life Sciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022.
Fri, 03 Feb 2023
Copy of Newspaper Publication
In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter and nine months ended December 31, 2022.Kindly take this information on record.

Technical Scans View Details >>

Mon, 06 Feb 2023
Closing Above Previous High Closing Above Previous High
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years
William %R Trending Up William %R Trending Up

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 245,571.93 1,011.40 -1.2%
Cipla Ltd. 83,115.65 1,028.00 -0.2%
Divi's Laboratories Ltd. 73,751.15 2,776.45 -0.1%
Dr. Reddy's Laboratories Ltd. 72,438.62 4,448.00 +2.3%
Apollo Hospitals Enterprise Ltd. 62,075.43 4,294.30 -0.6%
Torrent Pharmaceuticals Ltd. 52,113.83 1,533.05 -0.7%
Zydus Lifesciences Ltd. 47,588.78 473.30 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.30 1,011.40 -1.2%
Cipla Ltd. Consolidated 2022-12 31.50 1,028.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 30.77 2,776.45 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.89 4,448.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 73.90 4,294.30 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.13 1,533.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.09 473.30 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.44 1,011.40 -1.2%
Cipla Ltd. Consolidated 2022-12 3.66 1,028.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.93 2,776.45 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.29 4,448.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.37 4,294.30 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.23 1,533.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.76 473.30 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,011.40 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,028.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,776.45 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,448.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,294.30 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,533.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 473.30 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,011.40 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,028.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,776.45 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,448.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,294.30 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.30 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,011.40 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,028.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,776.45 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,448.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,294.30 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.30 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,011.40 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,028.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,776.45 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,448.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,294.30 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,533.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 473.30 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,011.40 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,028.00 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,776.45 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,448.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,294.30 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,533.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 473.30 +0.7%

FAQ's On RPG Life Sciences Ltd.

What is RPG Life Sciences share price?

Can I buy RPG Life Sciences shares now?

What is the Dividend Yield of RPG Life Sciences?

What is the Market Cap of RPG Life Sciences?

What are the key metrics to analyse RPG Life Sciences?

What is the 52 Week High and Low of RPG Life Sciences?

What is the trend of RPG Life Sciences share price?